Argen-X (ARGX)

280.10
+7.40(+2.71%)
  • Volume:
    106,218
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    276.00 - 283.10
  • Type:Equity
  • Market:Belgium
  • ISIN:NL0010832176

ARGX Overview

Prev. Close
272.7
Day's Range
276-283.1
Revenue
554.6M
Open
276.4
52 wk Range
201.4-314.6
EPS
-5.79
Volume
106,218
Market Cap
14.4B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
53,637
P/E Ratio
-
Beta
0.55
1-Year Change
35.58%
Shares Outstanding
51,398,663
Next Earnings Date
27 Oct 2021
What is your sentiment on Argen-X?
or
Market is currently closed. Voting is open during market hours.

Argen-X News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuySellStrong BuySellStrong Buy
SummaryStrong BuyNeutralStrong BuyNeutralStrong Buy

Argen-X Company Profile

Argen-X Company Profile

Employees
336
Market
Belgium

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.